未登录

B

Bei Jin

Zhongshan Ophthalmic Center

H指数:12

被引数:724

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Endothelial exosomes remodel chromatin accessibility and superenhancer in cancer cells to promote liver metastatic colonization

内皮细胞外泌体重塑癌细胞染色质可及性和超级增强子以促进肝转移定植

Signal Transduction and Targeted Therapy

IF52.7

2026-10-190

OAAI

The transcription factor HOXA9 induces expression of the chromatin modifier SMYD3 to drive leukemogenesis

转录因子HOXA9诱导染色质修饰因子SMYD3的表达，以驱动白血病发生。

Journal of Biological Chemistry

IF3.9

2025-07-010

OA

Effects of super-enhancers in cancer metastasis: mechanisms and therapeutic targets

超级增强子在癌症转移中的作用: 机制和治疗靶点

MOLECULAR CANCER

IF33.9

2024-06-072

OAAI

Antitumor activity of niclosamide-mediated oxidative stress against acute lymphoblastic leukemia

IF2.9

2024-05-302

PRE

Ferroptosis induced by DCPS depletion diminishes hepatic metastasis in uveal melanoma

BIOCHEMICAL PHARMACOLOGY

IF5.6

2023-07-016

OAAI

Verification of EZH2 as a druggable target in metastatic uveal melanoma

验证EZH2作为转移性葡萄膜黑色素瘤的可药靶标

MOLECULAR CANCER

IF33.9

2020-03-0449

OAAI

The antihelminthic drug niclosamide effectively inhibits the malignant phenotypes of uveal melanoma in vitro and in vivo (vol 7, pg 1447, 2017)

IF13.3

2020-01-010

OAAI

Neddylation Blockade Diminishes Hepatic Metastasis by Dampening Cancer Stem-Like Cells and Angiogenesis in Uveal Melanoma

CLINICAL CANCER RESEARCH

IF10.2

2018-07-3149

OAAI

Anthelmintic niclosamide suppresses transcription of BCR-ABL fusion oncogene via disabling Sp1 and induces apoptosis in imatinib-resistant CML cells harboring T315I mutant

CELL DEATH & DISEASE

IF9.6

2018-01-229

OAAI

Anthelmintic Niclosamide Disrupts the Interplay of p65 and FOXM1/β-catenin and Eradicates Leukemia Stem Cells in Chronic Myelogenous Leukemia

CLINICAL CANCER RESEARCH

IF10.2

2017-01-3154

OAAI

The antihelminthic drug niclosamide effectively inhibits the malignant phenotypes of uveal melanoma in vitro and in vivo

IF13.3

2017-01-0157

OAAI

Targeting methyltransferase PRMT5 eliminates leukemia stem cells in chronic myelogenous leukemia

JOURNAL OF CLINICAL INVESTIGATION

IF13.6

2016-09-19151

OA

Class III-specific HDAC inhibitor Tenovin-6 induces apoptosis, suppresses migration and eliminates cancer stem cells in uveal melanoma

SCIENTIFIC REPORTS

IF3.9

2016-03-0475

OAAI

Depletion of γ-catenin by Histone Deacetylase Inhibition Confers Elimination of CML Stem Cells in Combination with Imatinib

IF13.3

2016-01-0129

OAAI

Tenovin-6-mediated inhibition of SIRT1/2 induces apoptosis in acute lymphoblastic leukemia (ALL) cells and eliminates ALL stem/progenitor cells

IF3.4

2015-04-0735

OAAI

Ponatinib Induces Apoptosis in Imatinib-Resistant Human Mast Cells by Dephosphorylating Mutant D816V KIT and Silencing β-Catenin Signaling

MOLECULAR CANCER THERAPEUTICS

IF5.5

2014-05-0537

OAAI

Cyclin-Dependent Kinase 7/9 Inhibitor SNS-032 Abrogates FIP1-like-1 Platelet-Derived Growth Factor Receptor α and Bcr-Abl Oncogene Addiction in Malignant Hematologic Cells

CLINICAL CANCER RESEARCH

IF10.2

2012-04-0145

OA